Research
New Treatment Breakthrough for Chronic GVHD: Niktimvo™ Approved by FDA
In a significant development for patients battling chronic graft-versus-host disease (GVHD), the U.S. Food and Drug Administration (FDA) has granted approval to Niktimvo™ (axatilimab-csfr), a groundbreaking anti-CSF-1R antibody. This approval marks a pivotal moment in...
Incyte Announces US FDA Grants Priority Review For Axatilimab For Chronic GVHD Treatment
WILMINGTON, Del.--(BUSINESS WIRE)--Feb. 27, 2024-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for axatilimab, an anti-CSF-1R antibody, for the treatment...
Multiple Myeloma Updates – nbmtLINK Lunch & Learn at Noon
This month’s call in program will focus on Multiple Myeloma featuring featuring Dr. C. Ola Landgren, M.D., PhD, Professor of Medicine, Chief of Myeloma Division, Director of the Sylvester Myeloma Institute. Dr. Landgren’s clinical interests include novel therapeutics,...
Chronic Graft Versus Host Disease Webinar: Improving The Life Of Patients With GvHD Through Occupational Therapy, Good Nutrition, And Psychosocial Strategies
The National Bone Marrow Transplant Link, www.nbmtlink.org invites you to participate in a FREE webinar that will help you and your loved ones better understand Graft Versus Host Disease Thursday, Jan. 27, 20221:30 PM EST - Start time may vary by time zone To Register...
Dr. Ivan Maillard Leukemia Lymphoma Society Grant – An Update
One of the key objectives of the Foundation is to provide funding for research to prevent, treat and cure Graft vs. Host Disease. In 2019, the Foundation provided a designated Grant through the Leukemia Lymphoma Society (LLS) to Dr. Ivan Maillard, MD, PHD. We are...
nbmtLINK Lunch & Learn: COVID Vaccine and Booster Updates
This month’s telephone educational and support program will help cancer survivors and their families better understand the COVID vaccine and the important need for booster shots
nbmtLINK Webinar: Survivorship Issues Following a Bone Marrow/Stem Cell Transplant Including Changes Due to COVID-19
EVENT DATE AND TIME: Tuesday, Oct. 20, 2020 Noon to 1:30 pm EST Be sure to note the various time zone start times as indicated here: 12 pm (Noon): Eastern Time 11 am: Central Time 10 am: Mountain Time 9 am: Pacific Time Survivorship Issues Following a Bone Marrow/Stem...
2020 Graft vs Host Disease National Symposium
The 2020 Graft vs Host Disease National Symposium will be a virtual symposium at no charge.
Speakers who participated in the 2019 GvHD Symposium
KEYNOTE SPEAKER: Joseph H. Antin, MD Dana Farber Cancer Insitute Dr. Antin received his MD from Cornell University in 1978, and postgraduate training in hematology and medical oncology at DFCI and Brigham and Women's Hospital. He subsequently served as director of the...